Real world evidence (RWE) leader Syapse has announced a partnership with Merck. Together, the companies will utilize real world data (RWD) to understand the outcomes of patients living with cancer and improve care. The companies will leverage clinical, outcomes, and molecular data using the Syapse Learning Health Network.
Syapse CEO Ken Tarkoff remarks, “We’re very proud to be partnering with Merck’s CORE team on such a large, important project—the results of which will benefit so many researchers, clinicians, patients and industry stakeholders,” adding, “This work is a true example of what it means to use collaboration to advance the use of RWD and unlock its full potential—the ability to transform patient’s lives.” Read more here.
(Source: Syapse, 10/6/21)